網頁

Mass Life Science Center 10/4

 

 

Supporting the Angel Investor Community

 

The deadline is fast approaching for the MLSC's Angel Investor Tax Credit program, which aims to encourage investments in our gateway municipalities and throughout the Commonwealth. The program offers a tax credit to accredited investors interested in funding early-stage companies* engaged in life sciences research and development, commercialization and manufacturing in Massachusetts.

The MLSC will offer will offer two deadlines to apply and will remain open for the second deadline only if the funding cap has not been reached. Applications are accepted on a rolling basis and would be considered complete once both the investor and the company has each completed their portion of the application. If there are multiple investors in the same company, the company only has to submit one application for the current round of the program.

  • Deadline of October 29, 2021 at noon EST for submission of applications for qualifying investments made during the period January 1, 2021 to September 30, 2021.
  • Deadline of January 14, 2022 at noon EST for submission of applications for qualifying investments made during the period October 1, 2021 to December 31, 2021.

Apply now!

*Companies must have its’ principal location in Massachusetts with at least 50 percent of its employees located in the principal place of business, employs 20 or fewer full time employees and has gross revenues equal to or less than $500,000 in 2019.

 

 

 

Reboot Rx is Aiming to Save Lives with Overlooked Generic Drugs and AI Technology

 

“As a non-profit, we can stay completely focused on cancer patients and our mission,” said Laura Kleiman, PhD. “We can pursue the drugs with the best chance of rapidly saving lives around the world, regardless of their profitability.”

Read more about how Reboot Rx is utilizing AI-driven technology and generic drugs to take on the drug development system for the benefit of patients. The non-profit organization is among the 2021 awardees of the MLSC’s Massachusetts Next Generation Initiative (MassNextGen), a competitive program to support women entrepreneurs in early-stage life sciences companies.

 

 

Hear from Dr. Kleiman and other MassNextGen awardees for the "Women Who Lead in Life Sciences" virtual event this, Thursday, October 7. The MLSC is proud to partner with the Boston Business Journal for this gathering which will feature women in top roles discussing their personal stories and their views on how Life Science and Biotech companies in our region are evolving culture, policies and programs that will result in more equity and opportunity for women.

 

 

Apply Today: Upcoming Program Deadlines

 

Bits to Bytes (Deadline Nov. 19, 2021) grants for scientific projects that generate and analyze large datasets to answer pressing life science questions, and to attract and train data scientists in the Commonwealth. 

Novel Therapeutics Delivery (Deadline: Nov. 19, 2021) capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing, to targeted delivery, to biomaterials and more. 

Women's Health (Deadline: Nov. 19, 2021) supports collaborative projects that aim to improve the discovery, technical innovation, and/or analysis of datasets to answer pressing life science questions around women’s health.

Research Infrastructure (Deadline: Nov. 19, 2021) grants for capital projects that support the life sciences ecosystem in Massachusetts by enabling and supporting life sciences research and development. 

 

 

Opportunities to engage

 

MassBioEd’s 20th Anniversary Celebration, Honoring Champions for Biotechnology Education 2021
The event honors a school, teacher, and company for their outstanding advocacy for, and contributions to, life sciences education in Massachusetts. This year’s celebration will highlight the evolution and impact of MassBioEd’s programs over 20 years, looking to the next 20 years of continued success in opening career doors to underserved students and building a strong and diverse workforce.  October 26, 2021, 5:30-8:00 p.m.

Rewriting the Genome for Health: From Bench to Biotech
In this Harvard Medical School Executive Education live virtual webinar, Sekar Kathiresan, MD will discuss his journey from being a professor and cardiologist at Harvard Medical School to becoming the co-founder and chief executive officer of Verve Therapeutics. October 25, 2021, 12-1:00 p.m.

Student Intern & Employer Mashup
Hear from M2D2 resident startups who will share their experience hiring UMass Lowell students.
UMass Lowell students will share their experience gaining real-world, hands-on knowledge working for a startup. November 5, 2021, 11:00 a.m. - 1:00 p.m.

Barracuda Bowl Pitch Event
Join us for our annual “Shark Tank”-style pitch event! An impressive lineup of innovative medtech entrepreneurs will face tough questions from a panel of investors regarding their technologies, current stage of development, and financial projections. This event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area. November 16, 2021, 4:0-6:30 p.m.

 

Twitter

Facebook

LinkedIn

 

Copyright (c) 2020 Massachusetts Life Sciences Center, All Rights Reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

 

A must attend event: Women Who Lead in Life Sciences 

 

The MLSC is proud to sponsor this must attend event, Women Who Lead in Life Sciences, put on by the Boston Business Journal. The Oct. 7 event will sit down with female pioneers, in the ever-expanding sector of life sciences and biotech, to discuss how many women have made it into the C-Suite, the boardroom, the labs, and what does the leadership pipeline look like? The event will include the following two panels and dynamic panelists:

C-Suite Discussion:
Abbie Celniker, Ph.D. | Partner, Third Rock Ventures
Pearl Huang, Ph.D. | CEO, Cygnal Therapeutics
Nancy Simonian | CEO, Syros Pharmaceuticals

Emerging Leaders Discussion:
Laura Kleiman Ph.D. | Founder & CEO, Reboot Rx, and MassNextGen Awardee
Elizabeth O'Day, MPhil, PhD | CEO & Founder, Olaris, Inc. and MassNextGen Awardee 
Reshma Shetty | Co-founder, Ginkgo Bioworks
Noelle Hutchins, PhD | Investment Associate, Omega Funds

Don't miss out, secure your spot today. 

 

 

 

Portfolio Companies and Organizations Making Headlines

 

We are proud to see a number of MLSC supported portfolio companies making headlines including:

  • Ginkgo Bioworks began trading on the New York Stock Exchange after closing their SPAC merger with Soaring Eagle Acquisition Corp. Ginkgo, a Boston-based biotechnology company, uses their engineered high throughput automation platform to design custom organisms to impact all industries including agriculture, health, therapeutics, and biosecurity. The company is a recipient of our Tax Incentive program and was an active participant in the Internship Challenge program from 2009 to 2014.
  • Laura Indolfi, CEO of PanTher Therapeutics, was featured in Life Science Leader discussing a $5.4 million series A closing in June setting the way for PanTher's first clinical trial. Laura was an inaugural winner of the MLSC's MassNextGen program.
  • Rebion, a previous Milestone Achievement Program awardee, recently published their clinical trials showing 100% detection in children with the blinq vision scanner. The device detects amblyopia and strabismus, a common vision threatening eye condition in pediatrics. 
     
  • MedicaMetrix recently received CE mark approval for their ProstaMetrix device. The medical device is a minimally invasive tool that allows physicians to obtain early evaluations of their patients' prostate health. MedicaMetrix previously received an Accelerator Loan from the Center. 

 

 

 

Apply Today: Upcoming Program Deadlines

 

Angel Investor Tax Credit (Deadline: Oct. 29, 2021) encourages investment throughout the Commonwealth and in our gateway municipalities offering a tax credit to accredited investors interested in funding early-stage companies* engaged in life sciences research and development, commercialization and manufacturing in Massachusetts.

Bits to Bytes (Deadline Nov. 19, 2021) grants for scientific projects that generate and analyze large datasets to answer pressing life science questions, and to attract and train data scientists in the Commonwealth. 

Novel Therapeutics Delivery (Deadline: Nov. 19, 2021) capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing, to targeted delivery, to biomaterials and more. 

Women's Health (Deadline: Nov. 19, 2021) supports collaborative projects that aim to improve the discovery, technical innovation, and/or analysis of datasets to answer pressing life science questions around women’s health.

Research Infrastructure (Deadline: Nov. 19, 2021) grants for capital projects that support the life sciences ecosystem in Massachusetts by enabling and supporting life sciences research and development. 

 

 

Opportunities to engage

 

Life Sciences Apprenticeship Launch
Join us to celebrate the launch of the first Life Sciences Apprenticeship Program in Massachusetts, providing candidates an alternative pathway to careers in biomanufacturing and clinical trials. Guest remarks by President and CEO, Kenn Turner. Sept. 23, 2021, 10:30-11:30 a.m.

The Healing Power of Patient Stories
In this Harvard Medical School Executive Education webinar, Annie Brewster, MD will discuss the transformational power of sharing patient voices and stories. Sept. 30, 2021, 12-12:45 p.m.

LabCentral Ignite Golden Tickets Support Diverse Innovators
LabCentral Ignite Golden Tickets will be awarded to companies with high-impact science and a founder that identifies as underrepresented in the biotech industry. Deadline to apply: Oct. 1, 2021.

 

 

MassBio Events

-

-
MassBio Regional Mixer: Beverly

September 9, 2021
-
Transitioning to Leader (September 2021)

MassBioEd Training| September 13 - 16, 2021

-
Business of Biotech 101 (September 2021)

MassBioEd Training| September 13 - 16, 2021

-
Policymakers Live: Virtual Briefing With Senator Adam Hinds, Chairman, Senate Committee On Reimagining Massachusetts Post-Pandemic Resiliency

September 15, 2021
-
Science of Biotech 101 (September 2021)
MassBioEd Training| September 20 - 23, 2021
-
MassBio Edge Vendor Showcase: Cambridge
September 21, 2021
-
Ecosystem Workforce Challenges & Opportunities In The “Next Normal”

September 22, 2021
-
Cracking the Code to Employee Leave Management and Coordination
September 23, 2021

-
Life Sciences Apprenticeship Launch
MassBioEd | September 23, 2021
-
Patient Advocacy Summit

October 1, 2021
-
MassBio Oktoberfest

October 14, 2021
-
Town Hall: A Conversation with MassBio’s New Leadership Team
October 20, 2021
-
MassBioEd’s 20th Anniversary Celebration, Honoring Champions for Biotechnology Education 2021
MassBioEd | October 26, 2021

Conferences & Community Events
-

-
Ceremony: Harvard Catalyst Research Day
September 14, 2021
-
1st Annual Catherine J. Tobin Memorial Golf Classic – Sponsored by Tobin Scientific
September 14, 2021
-
Engineering the Next Wave of Immunotherapy
September 17, 2021
-
Mini Golf for Good
September 22, 2021

-
Breakfast Discussion- Decentralized trials

September 23, 2021
-
Forsyth dentech 2021
September 23, 2021
-
Life Sciences Apprenticeship Launch

MassBioEd | September 23, 2021
-
Fall MetroWest Life Science Mixer

September 29, 2021
-
AMCP Nexus 2021

October 18 - 21, 2021
-
World Cancer Leaders’ Summit
October 25 - 26, 2021

Webinars & Workshops
-

-
Public Health Conversation: WASTE: One Woman’s Fight Against America’s Dirty Secret

September 9, 2021

-
Public Health Conversation: 9/11. Twenty Years Later

September 10, 2021

-
Halloran Town Hall: Relieving the Recruitment Challenge with Smarter Study Design
September 10, 2021
-
Public Health Conversation: The Next Normal: Global Health

September 13, 2021
-
Predict the activity of new compounds using QSAR models with Flare™
September 14, 2021
-
6th Annual Bay Area Lifesciences Roundtable
September 14, 2021
-
State Drug Price Transparency Laws: Anticipating Reporting Responsibilities and Making Sure Your Company Is Prepared
September 15, 2021
-
Accelerated Stability Assessment Program (ASAP) for Oxygen Sensitivity
September 21, 2021
-
What does the Clin Pharm Plan for a Biologic Look Like?
September 21, 2021
-
The Genetics of Opioid Addiction: What We Know, What We Are Learning
September 30, 2021
-
Development of Mouse Pain Scales to Unlock the Sensory and Motivational Drives of Pain
September 30, 2021
-
The Healing Power of Patient Stories
September 30, 2021
-
High Theater: The Pre-IND Meeting (IN PERSON)

September 30, 2021
-
High Theater: The Pre-IND Meeting (VIRTUAL)

September 30, 2021

-
Public Health Conversation: Think. Teach. Do. Showcase.

September 30, 2021
-
Public Health Conversation: The Next Normal: Education and Health
October 5, 2021
-
Public Health Conversation: The Double Bottom Line: How Compassionate Leaders Captivate Hearts and Deliver Results
October 7, 2021
-
Seamless assay scheduling and management with Torx Test™
October 12, 2021
-
Public Health Conversation: The Next Normal: Food and Health
October 14, 2021
-
Streamlining collaboration and information delivery of outsourced discovery projects
October 21, 2021
-
Perk up for Perks: Fast Track, Accelerated Approval, Breakthrough Therapy and Priority Review Vouchers (IN PERSON)
October 21, 2021
-
Perk up for Perks: Fast Track, Accelerated Approval, Breakthrough Therapy and Priority Review Vouchers (VIRTUAL)
October 21, 2021
-
Public Health Conversation: The Next Normal: Civil Liberties and Health
October 21, 2021
-
Public Health Conversation: The Next Normal: Politics and Health
October 25, 2021

Diversity & Inclusion

-
Improving Diversity in Biotech by Leveraging SBIR/STTR Opportunities
September 14, 2021
-
LabCentral Ignite Golden Ticket Info Session
September 14, 2021
-
Attend Biotech Week Boston’s Diversity, Equity & Inclusion Summit FREE!
September 21, 2021
-
Maria Mitchell Women of Science Symposium

September 23 - 25, 2021- -
-
Diversity, Equity & Inclusion Certificate
September 23 - October 14, 2021

-

Hack4Equity

September 24 - September 26, 2021

Courses & Training
-

-
Building Long-term Habits for Busy People
September 8, 2021
-

Information Session – Boston College Clinical Research Certificate
September 8, 2021

-
Applied Risk Communication for the 21st Century

September 13 - 16, 2021

-
Transitioning to Leader (September 2021)

MassBioEd Training| September 13 - 16, 2021
-
Business of Biotech 101 (September 2021)

MassBioEd Training| September 13 - 16, 2021
-
Boston College – Clinical Research: Principles, Protocols and Procedures
September 16 - November 18, 2021
-
Online: Measurement, Design, and Analysis Methods for Health Outcomes Research
September 20 - 24, 2021
-
Science of Biotech 101 (September 2021)
MassBioEd Training| September 20 - 23, 2021
-
Biotechnology Project Management (Sept-Oct 2021)
MassBioEd Training| September 20 - October 12, 2021
-
An Apple a Day … A Delicious Way to Keep the Doctor Away
September 22, 2021
-
Online: Benefit-Cost Analysis
September 27 - October 1, 2021
-
Presenting with Persuasion, Clarity, and Strength (September 2021)
MassBioEd Training| September 27 - September 30, 2021
-
Fundamentals of Biomanufacturing – A Hands-On Approach
September 27 - November 16, 2021

-
Boston College – Project Management in Clinical Research
September 27 - October 25, 2021
-
Designing and Implementing AI Solutions for Health Care
September 28 - October 7, 2021
-
Grant Writing Workshop
September 30, 2021
-
Leadership Development for Physicians in Academic Health Centers
October 3 - 15, 2021
-
Community-Engaged Research

October 13 - December 17, 2021
-
Business of Biotech 201: From Molecule to Market, R&D and Regulatory Considerations (October 2021)
MassBioEd Training| October 18 - 21, 2021
-
Online: Leadership Strategies for Evolving Health Care Executives
October 18 - 22, 2021
-
Leadership Development for Physicians in Academic Health Centers

October 24 - November 5, 2021


 

MassBio releases their 2021 Industry Snapshot

 

Last week, MassBio released their 2021 Industry Snapshot report. A few takeaways include:

  • Massachusetts-headquartered companies raised $4.3 billion in venture capital funding in the first quarter of 2021 alone, after raising $5.8 billion in all of 2020
  • From 2020 to 2021, Massachusetts added nearly 5 million square feet of lab space with projections of an additional 20 million square feet of lab and bio- manufacturing space to be built out by 2024 with much of this expansion is happening outside of Cambridge & Boston

Read the full report.

 

 

 

What We're Reading

 

WBJ: WuXi Biologics approved for expansion of $60M Worcester facility
Key Sentence: The Chinese manufacturer WuXi Biologics, which is building a facility at The Reactory biomanufacturing campus on Belmont Street, was approved for a 5,000-square-foot expansion by the Worcester Planning Board on Wednesday night.

Endpoint News: Former Blueprint and Peloton vets team up to take on big players in growing hunt for a new type of small molecule
Key Sentence: Atavistik Bio uncloaked on Tuesday morning with a $60 million Series A round led by The Column Group and a new high-throughput screening platform to identify allosteric modulators of proteins. 

BBJ: A $440M investment, 3 months after launch of Flagship RNA startup
Key Sentence: The term "eRNA" refers to "endless RNA," the name for the specially engineered, circular ribonucleic acid that forms the backbone of Laronde's technology. 

 

 

Apply Today: Upcoming Program Deadlines

 

Angel Investor Tax Credit (Deadline: Oct. 29, 2021) encourages investment throughout the Commonwealth and in our gateway municipalities offering a tax credit to accredited investors interested in funding early-stage companies* engaged in life sciences research and development, commercialization and manufacturing in Massachusetts.

Bits to Bytes (Deadline Nov. 19, 2021) grants for scientific projects that generate and analyze large datasets to answer pressing life science questions, and to attract and train data scientists in the Commonwealth. 

Novel Therapeutics Delivery (Deadline: Nov. 19, 2021) capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing, to targeted delivery, to biomaterials and more. 

Women's Health (Deadline: Nov. 19, 2021) supports collaborative projects that aim to improve the discovery, technical innovation, and/or analysis of datasets to answer pressing life science questions around women’s health.

Research Infrastructure (Deadline: Nov. 19, 2021) grants for capital projects that support the life sciences ecosystem in Massachusetts by enabling and supporting life sciences research and development. 

 

 

Opportunities to engage

 

Life Sciences Apprenticeship Launch
Join us to celebrate the launch of the first Life Sciences Apprenticeship Program in Massachusetts, providing candidates an alternative pathway to careers in biomanufacturing and clinical trials. Guest remarks by President and CEO, Kenn Turner. Sept. 23, 2021, 10:30-11:30 a.m.

The Healing Power of Patient Stories
In this Harvard Medical School Executive Education webinar, Annie Brewster, MD will discuss the transformational power of sharing patient voices and stories. Sept. 30, 2021, 12-12:45 p.m.

LabCentral Ignite Golden Tickets Support Diverse Innovators
LabCentral Ignite Golden Tickets will be awarded to companies with high-impact science and a founder that identifies as underrepresented in the biotech industry. Deadline to apply: Oct. 1, 2021.

 

 

 

 

 

Employment Outlook for the Massachusetts Life Sciences Industry

 

The Massachusetts Biotechnology Education Foundation (MassBioEd) today released its 5th annual Life Sciences Employment Outlook, in collaboration with TEConomy Partners, which provides an overview of employment supply and demand in the Massachusetts life sciences industry. The report also brings together insights and implications from the data to inform the efforts of MassBioEd and other state education and workforce training leaders going forward.

Key findings include:

  • In 2020, state life sciences companies employed more than 89,000, an employment base which has grown by 67% over the last decade.
  • Extrapolating from historical employment growth leads to an increase of approximately 5,000 new jobs each year through 2024, adding 20,000 employees for a total expected employment of over 109,000 by the end of 2024.
  • Massachusetts college and university graduates are more concentrated in life science degree fields than their counterparts nationally (associate’s level and above).
  • Double-digit growth rates for Massachusetts’ college and university graduates over the last four years in nearly all leading life sciences fields is especially encouraging.

Key findings will be presented in detail at the 6th Annual Life Sciences Workforce Conference on June 2nd, 2021, an event uniquely devoted to bringing together the life sciences industry and academia to discuss training of the next generation of leaders.

 

 

Sneak peek of four innovative facilities in Massachusetts

 

During the 2021 BIO Digital conference, four Massachusetts companies provide tours of their innovative facilities followed by a thoughtful panel discussion with leaders from the ecosystem. Don't miss this opportunity.

Tuesday, June 15, 8-9:00 a.m.
Tour Session 1: Biomanufacturing and Beyond in Massachusetts, the State of Possible - featuring tours from Resilience and Lykan Bioscience

Wednesday, June 16, 8-9:00 a.m.
Tour Session 2: How Emerging Science from Massachusetts Improves Patient Lives Worldwide - featuring tours from Lyndra Therapeutics and Mustang Bio.

 

 

 

Opportunities to engage

 

The MLSC is a proud sponsor of MALSI+ 2021, connecting scientific innovators, entrepreneurs, business leaders, and investors to celebrate the many ways Massachusetts leads the nation in bringing translational science to the market. Register for the virtual conference on July 22. 

Interested in ways to engage before July 22, check out the MALSI Hub Cures Bi-weekly Speakers Series:

 

 

 

 

 

 

$22.4 Million in Committed Funding Announced for LabCentral 238

 

Last week, MLSC President and CEO Kenn Turner joined Housing & Economic Development Secretary and MLSC Board Co-Chair Mike Kennealy and LabCentral officials for the announcement of new commitments from Thermo Fisher and Waters Corp to support LabCentral 238. These new sponsors bring the total committed funding of the project to $22.4 million.
 
Thermo Fisher Scientific and Waters Corporation join Astellas and the MLSC as sponsors of the fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. In 2019, the MLSC announced a $5 million grant to LabCentral to fund this new resource for the life sciences industry and the local bio-economy. LabCentral 238 is currently under construction and is expected to open in November 2021.
 
The announcement event, which took place at LabCentral’s main facility at 700 Main Street in Cambridge, MA, also provided a spotlight to LabCentral Ignite, a new initiative with the goal of enhancing regional biotech innovation by stimulating a robust pipeline of diverse, qualified talent.
 
Read the announcement from LabCentral.
Watch the recording of the announcement event.

 

 

 

New Phase 2 Groups Eligible for COVID-19 Vaccine

 

Last week, the Baker-Polito Administration announced the next Phase 2 groups are eligible to get the vaccine. This includes people age 65-plus, residents and staff of affordable senior housing, and people with two-plus certain medical conditions (including asthma).

Details for booking can be found via the COVID-19 Vaccine Finder, which enables residents to search for a vaccination location and view appointment availability before scheduling. The tool can be accessed via the state’s vaccination website at www.mass.gov/COVIDvaccine.
 
The vaccine is safe, free and effective. It went through rigorous testing and followed the safety protocols used for all vaccines. When it's your turn, Trust the Facts, Get the Vax.

 

 

Apply Today: Upcoming Program Deadlines

 

Women's Health Innovation Grants (Deadline: March 12, 2021) to support translational research in women’s health and gender biology that will ultimately lead to commercial opportunities that address the lack of innovative technologies.

STEM Equipment and Professional Development Grants (Deadline: March 31, 2021) grants awarded to further advance and expand life sciences education at Massachusetts public high schools and middle schools through implementation of project and inquiry-based curriculum. 

Internship Challenge (applications accepted on a rolling basis) creates internship opportunities for college students interest in pursuing a career in the industry. students studying or living in the state, as well as students enrolled at Historically Black Colleges and Universities, are eligible to apply.

Data Science Internship (applications accepted on a rolling basis) creates new internship opportunities for qualified candidates at the Bachelor’s, Master’s, and Doctoral levels by enabling research institutions and small life sciences companies to hire paid interns for up to six months.

High School Apprenticeship Challenge (applications accepted on a rolling basis) facilitates and funds paid internships for underrepresented and economically disadvantaged high school students by subsidizing intern wages for small life sciences companies and academic researchers.

Seed Fund (applications accepted on a rolling basis) to advance innovative and promising life science companies in targeted geographies throughout the Commonwealth.

 

 

Stay Virtually Engaged

 

2021 Koch Institute Image Awards: Join us for the virtual opening of the 2021 Image Awards exhibition. On the tenth anniversary of the dedication of MIT’s Koch Institute research facility, peek inside our labs to glimpse new imagery that illuminates the scientific enterprise. Hear the stories behind this year’s award-winning visuals as we kick off our year-long celebration of the people, projects, and promise of integrative cancer research. March 4, 2021, 6:30-7:30 p.m.

Transitioning to Leader, For New Managers: Provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to help them get there. Approaches to effective communication and how to foster collaboration among teams, both remotely and in-person are discussed. March 8-12, 9-11:30 a.m.
 
Panel 3: Enhanced Strategies to Increase Diversity: The Education Development Center, the MLSC, and MassBioEd are convening a free, four-part panel series focused on growing and diversifying the state’s future Data Science workforce. This panel session will will focus on addressing a key component critical to the development of a strategic plan to extend and expand the early-stage Data Science pipeline. March 10, 2021, 10-11:30 a.m.

 

 


 

 

Enhanced strategies to increase diversity in the Data Science workforce
Given that a core strategy for growing the Data Science workforce is to increase its diversity, what have we learned from recent experience that might inform best practices?
 
Education Development Center (EDC), in partnership with the MLSC and the Massachusetts Biotechnology Education Foundation (MassBioEd), has convened a free, four-part online panel series focused on growing and diversifying the state’s Data Science workforce.
 
Each panel is addressing a key component in extending and expanding the early-stage Data Science pipeline. Join us for the latest gathering on Feb. 10 for a discussion on enhanced strategies to increase diversity.
 
MLSC President and CEO Kenn Turner will play the role of moderator for the panel, which will also include Bunker Hill Community College President Pam Eddinger, Bottom Line Executive Director Ginette Saimprevil, Coalition of Schools Educating Boys of Color Executive Director and Founding Member Ron Walker, and AnitaB.org President and CEO Brenda Darden Wilkerson.

Register today.
Apply Today: Upcoming Program Deadlines
Tax Incentive Program (Deadline: Feb. 5, 2021) to create long-term jobs, build a robust workforce, and propel the development of new therapies, devices, and scientific advancements that are improving patient health and well-being.

MassNextGen (Deadline: Feb. 12, 2021) to shift the paradigm to build a diverse ecosystem with equal representation. Supporting women-led early-stage life science companies with non-dilutive grant funding and access to a network of seasoned Executive Coaches.

STEM Equipment and Professional Development Grants (Deadline: March 31, 2021) grants awarded to further advance and expand life sciences education at Massachusetts public high schools and middle schools through implementation of project and inquiry-based curriculum. 

Women's Health Innovation Grants (Deadline: March 12, 2021) to support translational research in women’s health and gender biology that will ultimately lead to commercial opportunities that address the lack of innovative technologies.

Internship Challenge (applications accepted on a rolling basis) creates internship opportunities for college students interest in pursuing a career in the industry. students studying or living in the state, as well as students enrolled at Historically Black Colleges and Universities, are eligible to apply.

Data Science Internship (applications accepted on a rolling basis) creates new internship opportunities for qualified candidates at the Bachelor’s, Master’s, and Doctoral levels by enabling research institutions and small life sciences companies to hire paid interns for up to six months.

High School Apprenticeship Challenge (applications accepted on a rolling basis) facilitates and funds paid internships for underrepresented and economically disadvantaged high school students by subsidizing intern wages for small life sciences companies and academic researchers.

Seed Fund (applications accepted on a rolling basis) to advance innovative and promising life science companies in targeted geographies throughout the Commonwealth.

No comments:

Post a Comment